News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,469 Results
Type
Article (14323)
Company Profile (57)
Press Release (277088)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (74719)
Career Advice (451)
Deals (12230)
Drug Delivery (55)
Drug Development (32261)
Employer Resources (39)
FDA (9694)
Job Trends (5946)
News (131244)
Policy (12623)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (1437)
Accelerated approval (17)
Adcomms (9)
Allergies (89)
Alliances (22921)
ALS (98)
Alzheimer's disease (860)
Antibody-drug conjugate (ADC) (143)
Approvals (9988)
Artificial intelligence (326)
Autoimmune disease (148)
Automation (39)
Bankruptcy (76)
Best Places to Work (5378)
BIOSECURE Act (4)
Biosimilars (87)
Biotechnology (44)
Bladder cancer (95)
Brain cancer (38)
Breast cancer (328)
Cancer (2661)
Cardiovascular disease (174)
Career advice (381)
Career pathing (11)
CAR-T (161)
CDC (9)
Cell therapy (414)
Cervical cancer (21)
Clinical research (28166)
Collaboration (899)
Compensation (212)
Complete response letters (16)
COVID-19 (1214)
CRISPR (65)
C-suite (354)
Cystic fibrosis (49)
Data (3652)
Decentralized trials (3)
Denatured (7)
Depression (76)
Dermatology (38)
Diabetes (279)
Diagnostics (3400)
Digital health (36)
Diversity (3)
Diversity, equity & inclusion (12)
Drug discovery (135)
Drug pricing (66)
Drug shortages (6)
Duchenne muscular dystrophy (70)
Earnings (29715)
Editorial (16)
Employer branding (1)
Employer resources (37)
Events (40603)
Executive appointments (365)
FDA (11604)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (670)
Gene editing (123)
Generative AI (26)
Gene therapy (312)
GLP-1 (277)
Government (1854)
Grass and pollen (2)
Guidances (211)
Healthcare (9123)
HIV (31)
Huntington's disease (16)
IgA nephropathy (44)
Immunology and inflammation (123)
Immuno-oncology (41)
Indications (84)
Infectious disease (1352)
Inflammatory bowel disease (90)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (132)
Interviews (52)
IPO (5372)
IRA (16)
Job creations (782)
Job search strategy (326)
JPM (16)
Kidney cancer (8)
Labor market (6)
Layoffs (101)
Leadership (8)
Legal (2066)
Liver cancer (52)
Longevity (14)
Lung cancer (360)
Lymphoma (261)
Machine learning (25)
Management (17)
Manufacturing (409)
MASH (82)
Medical device (9689)
Medtech (9737)
Mergers & acquisitions (7344)
Metabolic disorders (522)
mRNA (65)
Multiple sclerosis (128)
NASH (7)
Neurodegenerative disease (189)
Neuropsychiatric disorders (36)
Neuroscience (1603)
Neurotech (1)
NextGen: Class of 2026 (2888)
Non-profit (1623)
Now hiring (13)
Obesity (150)
Opinion (121)
Ovarian cancer (98)
Pain (131)
Pancreatic cancer (124)
Parkinson's disease (158)
Partnered (15)
Patents (287)
Patient recruitment (291)
Peanut (44)
People (20713)
Pharmaceutical (13)
Pharmacy benefit managers (17)
Phase 1 (8913)
Phase 2 (12138)
Phase 3 (9518)
Pipeline (3611)
Policy (89)
Postmarket research (931)
Preclinical (3884)
Press Release (20)
Prostate cancer (126)
Psychedelics (10)
Radiopharmaceuticals (98)
Rare diseases (419)
Real estate (1886)
Recruiting (15)
Regulatory (11072)
Reports (21)
Research institute (1322)
Resumes & cover letters (85)
Rett syndrome (23)
RNA editing (5)
RSV (42)
Schizophrenia (80)
Series A (106)
Series B (83)
Service/supplier (4)
Sickle cell disease (38)
Special edition (4)
Spinal muscular atrophy (63)
Sponsored (27)
Startups (1426)
State (1)
Stomach cancer (7)
Supply chain (47)
Tariffs (12)
The Weekly (3)
Vaccines (452)
Venture capital (34)
Weight loss (79)
Women's health (49)
Worklife (2)
Date
Today (35)
Last 7 days (319)
Last 30 days (1245)
Last 365 days (13070)
2026 (3420)
2025 (13145)
2024 (15355)
2023 (17562)
2022 (23580)
2021 (25001)
2020 (24440)
2019 (20536)
2018 (15369)
2017 (14045)
2016 (13130)
2015 (15159)
2014 (10969)
2013 (9074)
2012 (10074)
2011 (10508)
2010 (9109)
Location
Africa (276)
Alabama (24)
Alaska (2)
Arizona (185)
Arkansas (10)
Asia (16073)
Australia (2397)
California (4825)
Canada (1224)
China (517)
Colorado (252)
Connecticut (243)
Delaware (186)
Europe (37056)
Florida (953)
Georgia (176)
Hawaii (1)
Idaho (29)
Illinois (400)
India (42)
Indiana (296)
Iowa (13)
Japan (246)
Kansas (39)
Kentucky (24)
Louisiana (21)
Maine (21)
Maryland (661)
Massachusetts (3552)
Michigan (184)
Minnesota (385)
Mississippi (4)
Missouri (86)
Montana (25)
Nebraska (13)
Nevada (67)
New Hampshire (52)
New Jersey (1639)
New Mexico (17)
New York (1593)
North Carolina (569)
North Dakota (5)
Northern California (2384)
Ohio (179)
Oklahoma (10)
Oregon (20)
Pennsylvania (894)
Puerto Rico (11)
Rhode Island (24)
South America (374)
South Carolina (40)
South Dakota (1)
Southern California (1839)
Tennessee (87)
Texas (944)
United States (18868)
Utah (182)
Vermont (1)
Virginia (129)
Washington D.C. (16)
Washington State (463)
West Virginia (2)
Wisconsin (46)
291,469 Results for "lds lyotopic dlivery systems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oncotelic to Present at the LD Micro Main Event XIX
October 21, 2025
·
9 min read
Press Releases
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo
November 5, 2025
·
7 min read
Press Releases
CytoDyn to Present at the LD Micro Main Event XIX Investor Conference
October 10, 2025
·
2 min read
Press Releases
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
October 7, 2025
·
4 min read
Press Releases
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
October 15, 2025
·
1 min read
Press Releases
NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21
October 10, 2025
·
1 min read
Press Releases
Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients
January 8, 2026
·
8 min read
Press Releases
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems
January 15, 2026
·
1 min read
Press Releases
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy
March 18, 2026
·
5 min read
Press Releases
Shimadzu Medical Systems USA renews HCAI Special Seismic Certification Approval for Radiographic System
March 26, 2026
·
1 min read
1 of 29,147
Next
